Back to search
FDAFDA · Food and drugs·Recall number D-1232-2015

Magnesium Sulfate Injection, USP, 50%, 20mL, Single dose Fliptop Vial, For IV or IM use, Rx only, Manufactured by Hospira, Inc. 4285 Wesleyan Blvd Rocky Mount, NC 27804 for Hospira, Inc. 275 N Field Drive, Lake Forest, IL 60045. NDC 0409-2168-02

Published July 15, 2015 · Recall initiated: May 19, 2015

Summary

FDA records drug Class III recall D-1232-2015, published July 15, 2015 and initiated May 19, 2015. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 106,900 vials; Lot: Lot #: 39-569-DK, Exp 3/1/2016. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed pH Specifications: 12 month stability testing

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
U.S. Nationwide, Kuwait, Bahrain and Israel.
Lot
Lot #: 39-569-DK, Exp 3/1/2016
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Magnesium Sulfate Injection, USP, 50%, 20mL, Single dose Fliptop Vial, For IV or IM use, Rx only, Manufactured by Hospira, Inc. 4285 Wesleyan Blvd Rocky Mount, NC 27804 for Hospira, Inc. 275 N Field Drive, Lake Forest, IL 60045. NDC 0409-2168-02 recalled?

Yes. FDA published recall D-1232-2015 on July 15, 2015. Reported hazard: Failed pH Specifications: 12 month stability testing

What should I do if I have this product?

Voluntary: Firm initiated · Letter